Envelope variants circulating as initial neutralization breadth developed in two HIV-infected subjects stimulate multiclade neutralizing antibodies in rabbits.

Envelope variants circulating as initial neutralization breadth developed in two HIV-infected subjects stimulate multiclade neutralizing antibodies in rabbits.

Item
http://www.wikidata.org/entity/Q34594513
Virological features associated with the development of broadly neutralizing antibodies to HIV-1HIV-1 VACCINES. HIV-1 neutralizing antibodies induced by native-like envelope trimersEmergence of broadly neutralizing antibodies and viral coevolution in two subjects during the early stages of infection with human immunodeficiency virus type 1Analysis of immunoglobulin transcripts and hypermutation following SHIV(AD8) infection and protein-plus-adjuvant immunizationStrategies to guide the antibody affinity maturation processSequential and Simultaneous Immunization of Rabbits with HIV-1 Envelope Glycoprotein SOSIP.664 Trimers from Clades A, B and C.Diversification in the HIV-1 Envelope Hyper-variable Domains V2, V4, and V5 and Higher Probability of Transmitted/Founder Envelope Glycosylation Favor the Development of Heterologous Neutralization BreadthLongitudinal Antigenic Sequences and Sites from Intra-Host Evolution (LASSIE) Identifies Immune-Selected HIV Variants.Achieving Potent Autologous Neutralizing Antibody Responses against Tier 2 HIV-1 Viruses by Strategic Selection of Envelope Immunogens.High-Resolution Longitudinal Study of HIV-1 Env Vaccine-Elicited B Cell Responses to the Virus Primary Receptor Binding Site Reveals Affinity Maturation and Clonal Persistence.HIV-1 escapes from N332-directed antibody neutralization in an elite neutralizer by envelope glycoprotein elongation and introduction of unusual disulfide bonds.Early short-term treatment with neutralizing human monoclonal antibodies halts SHIV infection in infant macaquesNative-like Env trimers as a platform for HIV-1 vaccine design.Development of novel replication-defective lymphocytic choriomeningitis virus vectors expressing SIV antigens.The HIV Genomic Incidence Assay Meets False Recency Rate and Mean Duration of Recency Infection Performance Standards.Reduced cell-associated DNA and improved viral control in macaques following passive transfer of a single anti-V2 monoclonal antibody and repeated SHIV challenges.
P2860

Envelope variants circulating as initial neutralization breadth developed in two HIV-infected subjects stimulate multiclade neutralizing antibodies in rabbits.

Item
http://www.wikidata.org/entity/Q34594513
description
2014 nî lūn-bûn
@nan
2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Envelope variants circulating ...... alizing antibodies in rabbits.
@ast
Envelope variants circulating ...... alizing antibodies in rabbits.
@en
Envelope variants circulating ...... alizing antibodies in rabbits.
@nl
type
label
Envelope variants circulating ...... alizing antibodies in rabbits.
@ast
Envelope variants circulating ...... alizing antibodies in rabbits.
@en
Envelope variants circulating ...... alizing antibodies in rabbits.
@nl
prefLabel
Envelope variants circulating ...... alizing antibodies in rabbits.
@ast
Envelope variants circulating ...... alizing antibodies in rabbits.
@en
Envelope variants circulating ...... alizing antibodies in rabbits.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P698
P921
P932
P356
P1433
P1476
Envelope variants circulating ...... ralizing antibodies in rabbits
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P698
P921
P932